Read article – Susan B. Roberts, the senior associate dean of foundational research at the Geisel School of Medicine, is featured in an article about health and longevity. Roberts notes that today, the average person spends about 10 years with chronic ailments, roughly twice the duration in the 60s.

Read article – Victor Ambros, a former professor at Dartmouth and the Geisel School of Medicine, has received a Nobel Prize for the discovery of microRNA.

Read article – Terri Lewinson, an associate professor at The Dartmouth Institute for health policy and clinical practice, is quoted in an article about the health effects of children living in extended-stay hotels. Lewinson said that extended-stay hotels do “offer a low-barrier option for families who have no other options.” (Picked up by MSN.)

Read article – Victor Ambros, a former professor at the Geisel School of Medicine, has received a Nobel Prize for the discovery of microRNA. (A press release is available on The Nobel Prize website.)

Read article – Hanover-born Victor Ambros, a former professor at Dartmouth and  the Geisel School of Medicine, received a Nobel Prize for the discovery of microRNA. Ambros’ spouse and longtime collaborator, Rosalind “Candy” Lee, was a research assistant in his Geisel lab and is the first author of the paper that reported the discovery that garnered the Nobel.

Read article – The Nobel Prize in physiology or medicine was awarded Monday to Americans Victor Ambros, a former professor at the Geisel School of Medicine, and Gary Ruvkun for their discovery of microRNA, tiny pieces of genetic material that alter how genes work at the cellular level and could lead to new ways of treating cancer.

Read article – Victor Ambros, a former professor at Dartmouth and the Geisel School of Medicine, has received a Nobel Prize for the discovery of microRNA. The article mentions that Ambros’ spouse and longtime collaborator, Rosalind “Candy” Lee, was a research assistant in his Geisel lab.

Read article – Steven Woloshin, MED ’96, a professor of The Dartmouth Institute, is quoted in an article about influencer marketing of weight loss drugs. “Marketing drugs through influencers is not really different from marketing drugs through traditional advertising,” Woloshin said. “The difference is that there is so much more of it, and they’re so much more creative and engaging, so they may be more effective.”